Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

BEHAV3D: an imaging and transcriptomics platform that unravels T cell antitumor activity

This study reveals a high level of behavioral heterogeneity in engineered T cells that target tumor organoids. Behavior-guided transcriptomics identified the gene signatures of T cells with highly potent serial cytotoxicity. Integration of the organoid and T cell transcriptomic data enabled the design of patient-specific combinatorial treatment to achieve an optimized response to cancer immunotherapies.

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: BEHAV3D, a three-dimensional imaging and transcriptomics platform.


  1. Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321–330 (2017). A report on the limitations of immunotherapy for solid tumors.

    CAS  Article  Google Scholar 

  2. Hegde, P. S. & Chen, D. S. Top 10 challenges in cancer immunotherapy. Immunity 52, 17–35 (2019). A Perspective article that presents the current challenges in optimization of cancer immunotherapy.

    Article  Google Scholar 

  3. Tuveson, D. & Clevers, H. Cancer modeling meets human organoid technology. Science 364, 952–955 (2019). A Review discussing the use of organoids as tumor models that recapitulate the original tumor characteristics.

    CAS  Article  Google Scholar 

  4. Ganesh, K. et al. A rectal cancer organoid platform to study individual responses to chemoradiation. Nat. Med. 25, 1607–1614 (2019). A research article showing the potential of organoids for personalized treatment.

    CAS  Article  Google Scholar 

  5. Crainiciuc, G. et al. Behavioural immune landscapes of inflammation. Nature 601, 415–421 (2022). A research article that demonstrates how behavioral profiling can be used to infer immune cell function.

    CAS  Article  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Dekkers, J. F. et al. Uncovering the mode of action of engineered T cells in patient cancer organoids. Nat. Biotechnol. (2022).

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

BEHAV3D: an imaging and transcriptomics platform that unravels T cell antitumor activity. Nat Biotechnol (2022).

Download citation

  • Published:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing